[Federal Register Volume 87, Number 99 (Monday, May 23, 2022)]
[Notices]
[Pages 31240-31241]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-10944]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, National Center for Injury 
Prevention and Control

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting for the Board of Scientific Counselors, 
National Center for Injury Prevention and Control (BSC, NCIPC). This 
meeting is closed to the public.

DATES: The meeting will be held on June 8, 2022, from 1 p.m. to 4 p.m., 
EDT (CLOSED).

ADDRESSES: Zoom Virtual Meeting.

FOR FURTHER INFORMATION CONTACT: Arlene Greenspan, DrPH, MPH, PT, 
Associate Director for Science, NCIPC, CDC, 4770 Buford Highway NE, 
Mailstop S-1069, Atlanta, Georgia 30341, Telephone: (770) 488-1279, 
Email: <a href="/cdn-cgi/l/email-protection#b6d8d5dfc6d5d4c5d5f6d5d2d598d1d9c0"><span class="__cf_email__" data-cfemail="85ebe6ecf5e6e7f6e6c5e6e1e6abe2eaf3">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: The meeting designated above will be closed 
to the public in accordance with provisions set forth in Section 
552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the 
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, CDC, pursuant to Public Law 92-463 (5 U.S.C. App. 
2).
    Purpose: The Board will: (1) Conduct, encourage, cooperate with, 
and assist other appropriate public health authorities, scientific 
institutions, and scientists in the conduct of research, 
investigations, experiments, demonstrations, and studies relating to 
the causes, diagnosis, treatment, control, and prevention of physical 
and mental diseases, and other impairments; (2) assist States and their 
political subdivisions in preventing and suppressing communicable and 
non-communicable diseases and other preventable conditions and in 
promoting health and well-being; and (3) conduct and assist in research 
and control activities related to injury. The Board of Scientific 
Counselors makes recommendations regarding policies, strategies, 
objectives, and priorities; and reviews progress toward injury 
prevention goals and provides evidence in injury prevention-related 
research and programs. The Board also provides advice on the 
appropriate balance of intramural and extramural research, as well as 
the structure, progress and performance of intramural programs. The 
Board is designed to provide guidance on extramural scientific program 
matters, including the: (1) Review of extramural research concepts for 
funding opportunity announcements; (2) conduct of Secondary Peer Review 
of extramural research grant, cooperative agreement, and contract 
applications received in response to funding opportunity announcements 
as they relate to the Center's programmatic balance and mission; (3) 
submission of secondary review recommendations to the Center Director 
of applications to be considered for funding support; (4) review of

[[Page 31241]]

research portfolios, and (5) review of program proposals.
    Matters to be Considered: The closed meeting will focus on the 
Secondary Peer Review of extramural research grant applications 
received in response to two (2) Notice of Funding Opportunities 
(NOFOs): (1) RFA-CE-22-002--``Grants to Support New Investigators in 
Conducting Research Related to Preventing Interpersonal Violence 
Impacting Children and Youth''; (2) RFA-CE-22-004--``Research Grants to 
Prevent Firearm-Related Violence and Injuries (R01)''; as well as PA-
21-259--PHS 2021-2 Omnibus Solicitation of the NIH, CDC and FDA for 
Small Business Innovation Research (SBIR) Grant Applications (Parent 
SBIR [R43/R44] Clinical Trial Not Allowed) and PA-21-260--PHS 2021-2 
Omnibus Solicitation of the NIH and CDC for SBIR Grant Applications 
(Parent SBIR [R43/R44] Clinical Trial Required). Agenda items are 
subject to change as priorities dictate.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-10944 Filed 5-20-22; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>